Novel regulators of Fgf23 expression and mineralization in Hyp bone.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Endocrinology

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1210/me.2009-0085PMID 19556340PMCID PMC2737552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure

  2009cited by this paper
• Endocrine functions of bone in mineral metabolism regulation.

  2008cited by this paper
• The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase.

  2008cited by this paper
• Carboxypeptidase Z (CPZ) Links Thyroid Hormone and Wnt Signaling Pathways in Growth Plate Chondrocytes

  2008cited by this paper
• Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone

  2008cited by this paper
• New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure

  2008cited by this paper
• Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

  2008cited by this paper
• Pathogenic role of Fgf23 in Dmp1-null mice.

  2008cited by this paper
• Direct Binding of Integrin αvβ3 to FGF1 Plays a Role in FGF1 Signaling*

  2008cited by this paper
• Distinct Roles of Heterogeneous Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b, a Ligand of the Receptor for Advanced Glycation End Products*♦

  2008cited by this paper
• Expression of secreted frizzled related protein 1, a Wnt antagonist, in brain, kidney, and skeleton is dispensable for normal embryonic development

  2008cited by this paper
• In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate

  2008cited by this paper
• Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.

  2008cited by this paper
• FGFR3 and FGFR4 do not mediate renal effects of FGF23.

  2008cited by this paper
• Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc

  2008cited by this paper
• VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5.

  2008cited by this paper
• Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice.

  2008cited by this paper
• Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen.

  2008cited by this paper
• Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis

  2007cited by this paper
• Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

  2007cited by this paper
• ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.

  2007cited by this paper
• Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate.

  2007cited by this paper
• Role of Matrix Gla Protein in Parathyroid Hormone Inhibition of Osteoblast Mineralization

  2006cited by this paper
• Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.

  2006cited by this paper
• Klotho converts canonical FGF receptor into a specific receptor for FGF23

  2006cited by this paper
• Constitutive expression of thrombospondin 1 in MC3T3‐E1 osteoblastic cells inhibits mineralization

  2006cited by this paper
• Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

  2006cited by this paper
• Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases.

  2006cited by this paper
• Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

  2006cited by this paper
• Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation.

  2006cited by this paper
• DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis

  2006cited by this paper
• Regulation of Fibroblast Growth Factor-23 Signaling by Klotho*

  2006cited by this paper
• Key Role of Src Kinase in S100B-induced Activation of the Receptor for Advanced Glycation End Products in Vascular Smooth Muscle Cells*

  2006cited by this paper
• Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

  2006cited by this paper
• Pathogenic role of Fgf23 in Hyp mice.

  2006cited by this paper
• Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation.

  2005cited by this paper
• BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks

  2005cited by this paper
• Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors.

  2005cited by this paper
• A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification

  2005cited by this paper
• Over‐expression of fibroblast growth factor‐2 causes defective bone mineralization and osteopenia in transgenic mice

  2005cited by this paper
• Evolution of Matrix and Bone γ-Carboxyglutamic Acid Proteins in Vertebrates*

  2005cited by this paper
• Mice with a Disruption of the Thrombospondin 3 Gene Differ in Geometric and Biomechanical Properties of Bone and Have Accelerated Development of the Femoral Head

  2005cited by this paper
• Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

  2004cited by this paper
• Bone Morphogenetic Protein-1/Tolloid-like Proteinases Process Dentin Matrix Protein-1*

  2004cited by this paper
• Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

  2004cited by this paper
• The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia.

  2004cited by this paper
• Genomic approaches to identifying transcriptional regulators of osteoblast differentiation

  2003cited by this paper
• Summaries of Affymetrix GeneChip probe level data.

  2003cited by this paper
• bFGF Administration Lowers the Phosphate Threshold for Mineralization in Bone Marrow Stromal Cells

  2003cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• Carboxypeptidase Z (CPZ) modulates Wnt signaling and regulates the development of skeletal elements in the chicken

  2003cited by this paper
• Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX*

  2003cited by this paper
• Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.

  2003cited by this paper
• Identification of genes regulated during osteoblastic differentiation by genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro.

  2003cited by this paper
• Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.

  2003cited by this paper
• The CCN family: a new stimulus package.

  2003cited by this paper
• Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization

  2002cited by this paper
• Comprehensive Microarray Analysis of Bone Morphogenetic Protein 2‐Induced Osteoblast Differentiation Resulting in the Identification of Novel Markers for Bone Development

  2002cited by this paper
• Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin.

  2002cited by this paper
• Discovery of osteoblast-associated genes using cDNA microarrays.

  2002cited by this paper
• Minimum information about a microarray experiment (MIAME)—toward standards for microarray data

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Analysis of recombinant Phex: an endopeptidase in search of a substrate.

  2001cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• Thrombospondin-4 Binds Specifically to Both Collagenous and Non-collagenous Extracellular Matrix Proteins via Its C-terminal Domains*

  2000cited by this paper
• Associations of FGF‐3 and FGF‐10 with signaling networks regulating tooth morphogenesis

  2000cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Osteomalacia in Hyp Mice Is Associated with Abnormal Phex Expression and with Altered Bone Matrix Protein Expression and Deposition*

  2000cited by this paper
• Developmental Expression and Tissue Distribution of Phex Protein: Effect of the Hyp Mutation and Relationship to Bone Markers

  2000cited by this paper
• The FGFR1 Inhibitor PD 173074 Selectively and Potently Antagonizes FGF‐2 Neurotrophic and Neurotropic Effects

  2000cited by this paper
• Intrinsic mineralization defect in Hyp mouse osteoblasts.

  1998cited by this paper
• Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine

  1998cited by this paper
• Cloning of P2Y6 cDNAs and identification of a pseudogene: comparison of P2Y receptor subtype expression in bone and brain tissues.

  1997cited by this paper
• Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

  1997cited by this paper
• BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning.

  1995cited by this paper
• Carbonic anhydrase II deficiency syndrome in a Belgian family is caused by a point mutation at an invariant histidine residue (107 His----Tyr): complete structure of the normal human CA II gene.

  1991cited by this paper

• Modulation of NMDA receptor signaling and zinc chelation prevent seizure-like events in a zebrafish model of SLC13A5 epilepsy

  2025cites this paper
• Fractal analysis of mandibular bone structure in children with amelogenesis imperfecta.

  2025cites this paper
• Fibroblast growth factor 23‐mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study

  2024cites this paper
• Organic phosphate but not inorganic phosphate regulates Fgf23 expression through MAPK and TGF-ꞵ signaling

  2024cites this paper
• Amyloid-β neuropathology induces bone loss in male mice by suppressing bone formation and enhancing bone resorption

  2024cites this paper
• Signalling interaction between β‐catenin and other signalling molecules during osteoarthritis development

  2024cites this paper
• The osteoblast sodium-citrate co-transporter (SLC13A5): a gatekeeper between global citrate homeostasis and tissue mineralization.

  2023cites this paper
• FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia

  2023cites this paper
• Differential gene expression in the calvarial and cortical bone of juvenile female mice

  2023cites this paper
• Endocrine Fibroblast Growth Factors in Relation to Stress Signaling

  2022cites this paper
• Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice

  2022cites this paper
• Atypical Presentation Of Hereditary Hypophosphatemic Rickets With Hypercalciuria Due To Digenic Mutations

  2022cites this paper
• Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp mice

  2022cites this paper
• High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench

  2022cites this paper
• Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice S

  2022cites this paper
• Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model

  2022cites this paper
• Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease

  2022cites this paper
• The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu

  2021cites this paper
• Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice.

  2021cites this paper
• The regulation of FGF23 production in bone and outside of bone

  2021cites this paper
• Endocrinology of Bone and Growth Disorders

  2021cites this paper
• Upstream Regulators of Fibroblast Growth Factor 23

  2021cites this paper
• Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood–brain barrier

  2021cites this paper
• Candidate gene screening for lipid deposition using combined transcriptomic and proteomic data from Nanyang black pigs

  2021cites this paper
• Les inhibiteurs de la voie Wnt dans un modèle animal d'insuffisance rénale chronique avec calcification vasculaire

  2020cites this paper
• Ablation of Enpp6 Results in Transient Bone Hypomineralization

  2020cites this paper
• Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiation

  2020cites this paper
• Sclerostin Directly Stimulates Osteocyte Synthesis of Fibroblast Growth Factor-23

  2020cites this paper
• Small molecule FGF23 inhibitors increase serum phosphate and improve skeletal abnormalities in Hyp mice

  2020cites this paper
• Osteocytic FGF23 and Its Kidney Function

  2020cites this paper
• Novel variants and uncommon cases among southern Chinese children with X-linked hypophosphatemia

  2020cites this paper
• Destroy to Rebuild: The Connection Between Bone Tissue Remodeling and Matrix Metalloproteinases

  2020cites this paper
• FGF23 Beyond the Kidney: A New Bone Mass Regulator in the General Population

  2020cites this paper
• Interplay Between FGF23, Phosphate, and Molecules Involved in Phosphate Sensing

  2019cites this paper
• A G protein – coupled , IP 3 / protein kinase C pathway controlling the synthesis of phosphaturic hormone FGF 23

  2019cites this paper
• A G protein-coupled, IP3/protein kinase C pathway controlling the synthesis of phosphaturic hormone FGF23.

  2019cites this paper
• Regulation of fibroblast growth factor 23 (FGF23) in health and disease

  2019cites this paper
• Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications

  2019cites this paper
• Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice

  2019cites this paper
• Phosphorus Disorders: Hypophosphatemic Rickets

  2019cites this paper
• 'Isolated' germline mosaicism in the phenotypically normal father of a girl with X-linked hypophosphatemic rickets.

  2019cites this paper
• Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders

  2019cites this paper
• Phosphate as a Signaling Molecule and Its Sensing Mechanism.

  2018influential citation
• Disorders of Phosphate Homeostasis

  2018cites this paper
• FGF23 Regulates Wnt/β-Catenin Signaling-Mediated Osteoarthritis in Mice Overexpressing High-Molecular-Weight FGF2.

  2018cites this paper
• Two novel variants of the PHEX gene in patients with X-linked dominant hypophosphatemic rickets and prenatal diagnosis for fetuses in these families

  2018cites this paper
• Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II

  2018cites this paper
• Class 3 semaphorins are transcriptionally regulated by 1,25(OH)2D3 in osteoblasts.

  2017cites this paper
• Tooth Hypoplasia for Differential Diagnosis of Childhood Epilepsy Associated with SLC13A5 Mutations

  2017cites this paper
• Genomics-Driven Drug Discovery Process

  2017cites this paper
• The longevity gene INDY (I'm Not Dead Yet) in metabolic control: Potential as pharmacological target.

  2017cites this paper
• Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice

  2017cites this paper
• Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells

  2017cites this paper
• Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia.

  2017cites this paper
• Bioactive glass-based surfaces induce differential gene expression profiling of osteoblasts.

  2017cites this paper
• Bone and Joint Deformity in Metabolic, Inflammatory, Neoplastic, Infectious, and Hematologic Disorders

  2016cites this paper
• Characterization of FN1–FGFR1 and novel FN1–FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors

  2016cites this paper
• Emerging roles of osteocytes in skeletal homeostasis and mineral metabolism

  2016influential citation
• Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition.

  2016cites this paper
• Regulation of hormone-sensitive renal phosphate transport.

  2015cites this paper
• Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease

  2015cites this paper
• Deficiency of Thrombospondin-4 in Mice Does Not Affect Skeletal Growth or Bone Mass Acquisition, but Causes a Transient Reduction of Articular Cartilage Thickness

  2015cites this paper
• FGF23 Is Endogenously Phosphorylated in Bone Cells

  2015cites this paper
• Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23.

  2015cites this paper
• The PTH-Vitamin D-FGF23 axis

  2015cites this paper
• Membrane and Integrative Nuclear Fibroblastic Growth Factor Receptor (FGFR) Regulation of FGF-23*

  2015cites this paper
• Dysregulated Gene Expression in the Primary Osteoblasts and Osteocytes Isolated from Hypophosphatemic Hyp Mice

  2014cites this paper
• FGF23: mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?

  2014cites this paper
• Circulating sclerostin in children and young adults with heritable bone disorders.

  2014cites this paper
• Vitamin D resistance in chronic kidney disease (CKD)

  2014cites this paper
• Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: The role of fibroblast growth factor 23

  2014cites this paper
• Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23

  2014cites this paper
• Common DNA variants predict tall stature in Europeans

  2014cites this paper
• Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.

  2014cites this paper
• An RNA‐seq protocol to identify mRNA expression changes in mouse diaphyseal bone: Applications in mice with bone property altering Lrp5 mutations

  2013cites this paper
• SLC13 family of Na⁺-coupled di- and tri-carboxylate/sulfate transporters.

  2013cites this paper
• Increased Col10a1 expression is not causative for the phenotype of Phex-deficient Hyp mice.

  2013cites this paper
• KALIRIN: NOVEL ROLE IN OSTEOCYTE FUNCTION Kornchanok Wayakanon, DDS Submitted to the Graduate Faculty of the School of Dentistry in fulfillment of the requirement for the Degree of Master of Science in Dentistry

  2013cites this paper
• The muscle-bone relationship in X-linked hypophosphatemic rickets.

  2013cites this paper
• Retinol deprivation partially rescues the skeletal mineralization defects of Phex-deficient Hyp mice.

  2013cites this paper
• Oncogenic osteomalacia -- hypophosphataemic spectrum from "benignancy" to "malignancy".

  2013cites this paper
• Calcium regulates FGF-23 expression in bone.

  2013cites this paper
• Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X‐linked hypophosphatemia

  2013cites this paper
• A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease.

  2013cites this paper
• Hypophosphatemia and growth

  2013cites this paper
• Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family

  2013cites this paper
• The Role of INDY in Metabolic Regulation

  2013cites this paper
• Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro

  2013cites this paper
• The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.

  2013cites this paper
• A protective role for FGF-23 in local defence against disrupted arterial wall integrity?

  2013cites this paper
• Novel Bone Endocrine Networks Integrating Mineral and Energy Metabolism

  2013cites this paper
• Antibody-Mediated Activation of FGFR1 Induces FGF23 Production and Hypophosphatemia

  2013cites this paper
• FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6.

  2013cites this paper
• 74. Disorders of Phosphate Homeostasis

  2013cites this paper
• Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.

  2012cites this paper
• Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism

  2012cites this paper
• Collagen XXIV (Col24α1) Promotes Osteoblastic Differentiation and Mineralization through TGF-β/Smads Signaling Pathway

  2012cites this paper
• Mutation in Phex Gene Predisposes BALB/c-PhexHyp-Duk/Y Mice to Otitis Media

  2012cites this paper
• Regulation and function of the FGF23/klotho endocrine pathways.

  2012cites this paper
• Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.

  2012cites this paper